The inquiry, announced by class action attorney Juan Monteverde, seeks to evaluate the fairness of the proposed acquisition. Monteverde & Associates, which maintains offices in the Empire State Building, is currently soliciting inquiries from common stockholders concerned about the valuation of the deal. The firm, recognized in the 2025 ISS Securities Class Action Services Report, is reviewing whether the board of directors fulfilled their fiduciary duties throughout the negotiation process with AbbVie.
In section Releases
Monteverde & Associates Opens Inquiry Into Apogee Therapeutics Sale
Shareholders of Apogee Therapeutics, Inc. are facing a potential buyout by AbbVie Inc. that promises a cash payout of $135.11 per share. Now, New York-based Monteverde & Associates PC has launched an official investigation into the transaction to determine if the terms provide adequate value to investors.
Investors holding shares in the NASDAQ-listed company can contact the firm to review their legal standing. According to the firm, the investigation is provided at no cost or obligation to shareholders. Monteverde & Associates specializes in securities litigation and has a history of representing clients in state and federal courts, including the U.S. Supreme Court.
Comments (0)
No comments yet. Be the first!